30 /100
MEDIUM RISK
Score updated May 30, 2026

SIGY — Sigyn Therapeutics, Inc. Dilution Risk Tracker

Track SIGY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SIGY — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
60
⚠️ Warrant Exposure
70
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
45%
🔄 Reverse Split 55%
• 50-day avg $0.04 below $1 exchange minimum
📜 Warrant Exercise 50%
• Massive warrant overhang: 35% of shares outstanding
• Elevated warrant risk score (70/100)
🔁 Convertible Conversion 15%
• Convertible debt present: 8.8% potential dilution
🔔 Track SIGY — Get forecast alerts →

💹 Market Data

Market Cap$56.2K
Shares Outstanding1.61M
Float889.2K
Cash$85.6K
Debt$2.81M
Short InterestN/A

🏛 Institutional Holdings

5.3% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track SIGY for full holder detail →

📉 Short Interest

Short Interest2.7K
Days to Cover1.0
% of Float0.3%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2024
xbrl XBRL CONVERTIBLE Dec 31, 2024
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track SIGY Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SIGY — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for SIGY
📊 SIGY FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SIGY Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.